Vienna - Delayed Quote EUR
Vertex Pharmaceuticals Incorporated (VRTX.VI)
440.30
-5.40
(-1.21%)
At close: May 2 at 5:32:33 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ALTSHULER DAVID Officer | Sale | Mar 13, 2025 | 23,281 |
AMBROSE KRISTEN Officer | Sale | Feb 25, 2025 | 9,086 |
ARBUCKLE STUART A Chief Operating Officer | Stock Award(Grant) | Feb 12, 2025 | 77,586 |
ATKINSON EDWARD MORROW III Chief Technology Officer | Sale | Feb 27, 2025 | 19,352 |
BILLER JONATHAN PRIM Officer | Sale | Feb 18, 2025 | 17,606 |
KEWALRAMANI RESHMA Chief Executive Officer | Stock Award(Grant) | Feb 12, 2025 | 135,933 |
LEIDEN JEFFREY M Officer and Director | Stock Award(Grant) | Feb 12, 2025 | 30,532 |
SACHDEV AMIT Officer | Stock Award(Grant) | Feb 12, 2025 | 77,684 |
TATSIS OURANIA Officer | Sale | Mar 10, 2025 | 51,239 |
WAGNER CHARLES F JR Chief Financial Officer | Sale | Mar 10, 2025 | 51,671 |
Related Tickers
0OT.DU Ocular Therapeutix Inc
7.67
+4.78%
1T3.BE Syndax Pharmaceuticals Inc
12.00
-4.00%
HTD.SG Corcept Therapeutics Inc
64.08
+1.65%
ALZCUR.ST AlzeCure Pharma AB (publ)
2.4500
+3.38%
AC6.F AlzeCure Pharma AB (publ)
0.1755
-0.85%
22UA.BE BioNTech SE
92.80
+1.98%
22UA.MU BioNTech SE
91.15
-0.16%
BNTX.VI BioNTech SE
92.25
+1.26%
NKB2.F TG Therapeutics, Inc.
39.98
+4.98%
22UA.DU BioNTech SE
92.65
+1.87%